1.
J Hepatol
; 23(1): 95-7, 1995 Jul.
Article
in English
| MEDLINE
| ID: mdl-8530816
ABSTRACT
The authors describe three cases of tamoxifen-associated steatohepatitis, which resulted from a daily dosage of 20 mg used as the adjuvant treatment of breast carcinoma. Liver tests became normal after discontinuation of tamoxifen.